{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T06:20:09Z","timestamp":1766989209705,"version":"3.48.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Undergraduate Training Program for Innovation and Entrepreneurship","award":["202213705005"],"award-info":[{"award-number":["202213705005"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170645"],"award-info":[{"award-number":["82170645"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"crossref","award":["No. 2024NSFSC0735"],"award-info":[{"award-number":["No. 2024NSFSC0735"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"crossref","award":["No. 2024NSFSC0735"],"award-info":[{"award-number":["No. 2024NSFSC0735"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CMC Excellent-talent Program","award":["2024kjTzn04"],"award-info":[{"award-number":["2024kjTzn04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11403-4","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T06:18:20Z","timestamp":1766989100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deguelin suppresses Nalm6 leukemia cell proliferation through lactate accumulation and ATP depletion"],"prefix":"10.1007","volume":"53","author":[{"given":"Xingyan","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juncheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yantang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunfen","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"11403_CR1","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard F, Mohty M (2020) Acute lymphoblastic leukaemia. Lancet 395:1146\u20131162. https:\/\/doi.org\/10.1016\/S0140-6736(19)33018-1","journal-title":"Lancet"},{"key":"11403_CR2","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa2411680","volume":"392","author":"S Gupta","year":"2025","unstructured":"Gupta S, Rau RE, Kairalla JA, Rabin KR, Wang C, Angiolillo AL, Alexander S, Carroll AJ, Conway S, Gore L et al (2025) Blinatumomab in Standard-Risk B-Cell acute lymphoblastic leukemia in children. N Engl J Med 392:875\u2013891. https:\/\/doi.org\/10.1056\/NEJMoa2411680","journal-title":"N Engl J Med"},{"key":"11403_CR3","doi-asserted-by":"publisher","first-page":"e29937","DOI":"10.1002\/pbc.29937","volume":"69","author":"CW Elgarten","year":"2022","unstructured":"Elgarten CW, Thompson JC, Angiolillo A, Chen Z, Conway S, Devidas M, Gupta S, Kairalla JA, McNeer JL, O\u2019Brien MM et al (2022) Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the children\u2019s oncology group. Pediatr Blood Cancer 69:e29937. https:\/\/doi.org\/10.1002\/pbc.29937","journal-title":"Pediatr Blood Cancer"},{"key":"11403_CR4","doi-asserted-by":"publisher","first-page":"101042","DOI":"10.1016\/j.blre.2023.101042","volume":"59","author":"D Kegyes","year":"2023","unstructured":"Kegyes D, Jitaru C, Ghiaur G, Ciurea S, Hoelzer D, Tomuleasa C, Gale RP (2023) Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemia. Blood Rev 59:101042. https:\/\/doi.org\/10.1016\/j.blre.2023.101042","journal-title":"Blood Rev"},{"key":"11403_CR5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1182\/bloodadvances.2019000952","volume":"4","author":"M Pennisi","year":"2020","unstructured":"Pennisi M, Jain T, Santomasso BD, Mead E, Wudhikarn K, Silverberg ML, Batlevi Y, Shouval R, Devlin SM, Batlevi C et al (2020) Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management. Blood Adv 4:676\u2013686. https:\/\/doi.org\/10.1182\/bloodadvances.2019000952","journal-title":"Blood Adv"},{"key":"11403_CR6","doi-asserted-by":"publisher","first-page":"1396490","DOI":"10.3389\/fonc.2024.1396490","volume":"14","author":"CJ Ferreri","year":"2024","unstructured":"Ferreri CJ, Bhutani M (2024) Mechanisms and management of CAR T toxicity. Front Oncol 14:1396490. https:\/\/doi.org\/10.3389\/fonc.2024.1396490","journal-title":"Front Oncol"},{"key":"11403_CR7","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S2352-3026(23)00064-9","volume":"10","author":"NJ Short","year":"2023","unstructured":"Short NJ, Kantarjian H (2023) Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past. Lancet Haematol 10:e382\u2013e388. https:\/\/doi.org\/10.1016\/S2352-3026(23)00064-9","journal-title":"Lancet Haematol"},{"key":"11403_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejca.2021.12.029","volume":"164","author":"E Brivio","year":"2022","unstructured":"Brivio E, Baruchel A, Beishuizen A, Bourquin JP, Brown PA, Cooper T, Gore L, Kolb EA, Locatelli F, Maude SL et al (2022) Targeted inhibitors and antibody immunotherapies: novel therapies for paediatric leukaemia and lymphoma. Eur J Cancer 164:1\u201317. https:\/\/doi.org\/10.1016\/j.ejca.2021.12.029","journal-title":"Eur J Cancer"},{"key":"11403_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2023.01.007","volume":"90","author":"M Singh","year":"2023","unstructured":"Singh M, Afonso J, Sharma D, Gupta R, Kumar V, Rani R, Baltazar F, Kumar V (2023) Targeting monocarboxylate transporters (MCTs) in cancer: how close are we to the clinics? Semin Cancer Biol 90:1\u201314. https:\/\/doi.org\/10.1016\/j.semcancer.2023.01.007","journal-title":"Semin Cancer Biol"},{"key":"11403_CR10","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1158\/0008-5472.CAN-24-0019","volume":"84","author":"E Boet","year":"2024","unstructured":"Boet E, Sarry JE (2024) Targeting metabolic dependencies fueling the TCA cycle to circumvent therapy resistance in acute myeloid leukemia. Cancer Res 84:950\u2013952. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-0019","journal-title":"Cancer Res"},{"key":"11403_CR11","doi-asserted-by":"publisher","first-page":"7190","DOI":"10.1038\/s41467-021-27329-x","volume":"12","author":"T Pemovska","year":"2021","unstructured":"Pemovska T, Bigenzahn JW, Srndic I, Lercher A, Bergthaler A, Cesar-Razquin A, Kartnig F, Kornauth C, Valent P, Staber PB et al (2021) Metabolic drug survey highlights cancer cell dependencies and vulnerabilities. Nat Commun 12:7190. https:\/\/doi.org\/10.1038\/s41467-021-27329-x","journal-title":"Nat Commun"},{"key":"11403_CR12","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1182\/blood.2020005185","volume":"136","author":"D Stenger","year":"2020","unstructured":"Stenger D, Stief TA, Kaeuferle T, Willier S, Rataj F, Schober K, Vick B, Lotfi R, Wagner B, Grunewald TGP et al (2020) Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR\/Cas9-mediated TCR knockout CAR. Blood 136:1407\u20131418. https:\/\/doi.org\/10.1182\/blood.2020005185","journal-title":"Blood"},{"key":"11403_CR13","doi-asserted-by":"publisher","unstructured":"Zhao K, Jing L, Cui W, Zhang J, Wu J, He J, Lai Y, Liu Y, Luo X (2025) The inhibitory effect of low concentrations of Deguelin on activated T cell proliferation. 60:515\u2013521. https:\/\/doi.org\/10.11669\/cpj.2025.05.009","DOI":"10.11669\/cpj.2025.05.009"},{"key":"11403_CR14","doi-asserted-by":"publisher","first-page":"116620","DOI":"10.1016\/j.ejmech.2024.116620","volume":"276","author":"MT La","year":"2024","unstructured":"La MT, Hoang VH, Sahu R, Nguyen CT, Nam G, Park HJ, Park M, Kim YJ, Kim JY, Ann J et al (2024) Discovery of Indazole inhibitors for heat shock protein 90 as anti-cancer agents. Eur J Med Chem 276:116620. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116620","journal-title":"Eur J Med Chem"},{"key":"11403_CR15","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.4049\/jimmunol.177.8.5612","volume":"177","author":"AS Nair","year":"2006","unstructured":"Nair AS, Shishodia S, Ahn KS, Kunnumakkara AB, Sethi G, Aggarwal BB (2006) Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and Inhibition of cellular invasion. J Immunol 177:5612\u20135622. https:\/\/doi.org\/10.4049\/jimmunol.177.8.5612","journal-title":"J Immunol"},{"key":"11403_CR16","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1007\/s10620-012-2237-x","volume":"57","author":"HW Kang","year":"2012","unstructured":"Kang HW, Kim JM, Cha MY, Jung HC, Song IS, Kim JS (2012) Deguelin, an Akt inhibitor, down-regulates NF-kappaB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice. Dig Dis Sci 57:2873\u20132882. https:\/\/doi.org\/10.1007\/s10620-012-2237-x","journal-title":"Dig Dis Sci"},{"key":"11403_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41419-020-2344-0","volume":"11","author":"F Gao","year":"2020","unstructured":"Gao F, Yu X, Li M, Zhou L, Liu W, Li W, Liu H (2020) Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3beta\/FBW7-mediated Mcl-1 destabilization. Cell Death Dis 11:143. https:\/\/doi.org\/10.1038\/s41419-020-2344-0","journal-title":"Cell Death Dis"},{"key":"11403_CR18","doi-asserted-by":"publisher","unstructured":"Lu G, Yao Y, Zhang X, Cui D, Zhou J (2022) Deguelin Attenuates Non-Small-Cell Lung Cancer Cell Metastasis by Upregulating PTEN\/KLF4\/EMT Signaling Pathway. Dis Markers 2022, 4090346. https:\/\/doi.org\/10.1155\/2022\/4090346","DOI":"10.1155\/2022\/4090346"},{"key":"11403_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/1759-7714.12444","volume":"8","author":"D Zhao","year":"2017","unstructured":"Zhao D, Han W, Liu X, Cui D, Chen Y (2017) Deguelin inhibits epithelial-to-mesenchymal transition and metastasis of human non-small cell lung cancer cells by regulating NIMA-related kinase 2. Thorac Cancer 8:320\u2013327. https:\/\/doi.org\/10.1111\/1759-7714.12444","journal-title":"Thorac Cancer"},{"key":"11403_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/CMAR.S169476","volume":"11","author":"L Chen","year":"2019","unstructured":"Chen L, Jiang K, Chen H, Tang Y, Zhou X, Tan Y, Yuan Y, Xiao Q, Ding K (2019) Deguelin induces apoptosis in colorectal cancer cells by activating the p38 MAPK pathway. Cancer Manag Res 11:95\u2013105. https:\/\/doi.org\/10.2147\/CMAR.S169476","journal-title":"Cancer Manag Res"},{"key":"11403_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ebiom.2017.10.030","volume":"26","author":"X Yu","year":"2017","unstructured":"Yu X, Liang Q, Liu W, Zhou L, Li W, Liu H (2017) Deguelin, an Aurora B kinase Inhibitor, exhibits potent Anti-Tumor effect in human esophageal squamous cell carcinoma. EBioMedicine 26:100\u2013111. https:\/\/doi.org\/10.1016\/j.ebiom.2017.10.030","journal-title":"EBioMedicine"},{"key":"11403_CR22","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1038\/onc.2012.413","volume":"32","author":"SR Boreddy","year":"2013","unstructured":"Boreddy SR, Srivastava SK (2013) Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model. Oncogene 32:3980\u20133991. https:\/\/doi.org\/10.1038\/onc.2012.413","journal-title":"Oncogene"},{"key":"11403_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.11669\/cpj.2025.05.00","volume":"60","author":"K Zhao","year":"2025","unstructured":"Zhao K, Jing L, Cui W, Zhang J, Wu J, He J, Lai Y, Liu Y, Luo X (2025) The inhibitory effect of low dose Deguelin on activated T cell proliferation. Chin Pharm J 60:10. https:\/\/doi.org\/10.11669\/cpj.2025.05.00","journal-title":"Chin Pharm J"},{"key":"11403_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1158\/0008-5472.CAN-15-1492","volume":"76","author":"SC Lee","year":"2016","unstructured":"Lee SC, Min HY, Choi H, Bae SY, Park KH, Hyun SY, Lee HJ, Moon J, Park SH, Kim JY et al (2016) Deguelin analogue SH-1242 inhibits Hsp90 activity and exerts potent anticancer efficacy with limited neurotoxicity. Cancer Res 76:686\u2013699. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1492","journal-title":"Cancer Res"},{"key":"11403_CR25","doi-asserted-by":"publisher","first-page":"101850","DOI":"10.1016\/j.tranon.2023.101850","volume":"40","author":"W Bai","year":"2024","unstructured":"Bai W, Liu D, Cheng Q, Yang X, Zhu L, Qin L, Fang J (2024) Tetraarsenic tetrasulfide triggers ROS-induced apoptosis and ferroptosis in B-cell acute lymphoblastic leukaemia by targeting HK2. Transl Oncol 40:101850. https:\/\/doi.org\/10.1016\/j.tranon.2023.101850","journal-title":"Transl Oncol"},{"key":"11403_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trsl.2018.02.002","volume":"197","author":"M Patel","year":"2018","unstructured":"Patel M, Horgan PG, McMillan DC, Edwards J (2018) NF-kappaB pathways in the development and progression of colorectal cancer. Transl Res 197:43\u201356. https:\/\/doi.org\/10.1016\/j.trsl.2018.02.002","journal-title":"Transl Res"},{"key":"11403_CR27","doi-asserted-by":"publisher","first-page":"215593","DOI":"10.1016\/j.canlet.2022.215593","volume":"535","author":"M Artemenko","year":"2022","unstructured":"Artemenko M, Zhong SSW, To SKY, Wong (2022) A.S.T. p70 S6 kinase as a therapeutic target in cancers: more than just an mTOR effector. Cancer Lett 535:215593. https:\/\/doi.org\/10.1016\/j.canlet.2022.215593","journal-title":"Cancer Lett"},{"key":"11403_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41419-024-06626-5","volume":"15","author":"K Zhou","year":"2024","unstructured":"Zhou K, Wu C, Cheng W, Zhang B, Wei R, Cheng D, Li Y, Cao Y, Zhang W, Yao Z et al (2024) Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via PI3K-AKT signaling pathway-mediated keratin 14 degradation. Cell Death Dis 15:252. https:\/\/doi.org\/10.1038\/s41419-024-06626-5","journal-title":"Cell Death Dis"},{"key":"11403_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s42255-020-0172-2","volume":"2","author":"RJ DeBerardinis","year":"2020","unstructured":"DeBerardinis RJ, Chandel NS (2020) We need to talk about the Warburg effect. Nat Metab 2:127\u2013129. https:\/\/doi.org\/10.1038\/s42255-020-0172-2","journal-title":"Nat Metab"},{"key":"11403_CR30","doi-asserted-by":"publisher","first-page":"105935","DOI":"10.1016\/j.phrs.2021.105935","volume":"174","author":"ZY Lin","year":"2021","unstructured":"Lin ZY, Yun QZ, Wu L, Zhang TW, Yao TZ (2021) Pharmacological basis and new insights of Deguelin concerning its anticancer effects. Pharmacol Res 174:105935. https:\/\/doi.org\/10.1016\/j.phrs.2021.105935","journal-title":"Pharmacol Res"},{"key":"11403_CR31","doi-asserted-by":"publisher","unstructured":"Shenker BJ, Walker LP, Zekavat A, Korostoff J, Boesze-Battaglia K (2022) Aggregatibacter actinomycetemcomitans cytolethal distending Toxin-Induces cell cycle arrest in a glycogen synthase kinase (GSK)-3-Dependent manner in oral keratinocytes. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms231911831","DOI":"10.3390\/ijms231911831"},{"key":"11403_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12935-015-0166-4","volume":"15","author":"H Xu","year":"2015","unstructured":"Xu H, Li X, Ding W, Zeng X, Kong H, Wang H, Xie W (2015) Deguelin induces the apoptosis of lung cancer cells through regulating a ROS driven Akt pathway. Cancer Cell Int 15:25. https:\/\/doi.org\/10.1186\/s12935-015-0166-4","journal-title":"Cancer Cell Int"},{"key":"11403_CR33","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.cell.2015.10.001","volume":"163","author":"GS Shadel","year":"2015","unstructured":"Shadel GS, Horvath TL (2015) Mitochondrial ROS signaling in organismal homeostasis. Cell 163:560\u2013569. https:\/\/doi.org\/10.1016\/j.cell.2015.10.001","journal-title":"Cell"},{"key":"11403_CR34","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden MG, DeBerardinis RJ (2017) Understanding the intersections between metabolism and cancer biology. Cell 168:657\u2013669. https:\/\/doi.org\/10.1016\/j.cell.2016.12.039","journal-title":"Cell"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11403-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11403-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11403-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T06:18:23Z","timestamp":1766989103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11403-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11403"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11403-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics, consent to Participate, and consent to publish declarations"}}],"article-number":"232"}}